ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,401Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 1456

$1.31M Total Retail Price of All Prescriptions

Rank: 58 out of 1456

794 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 794 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

38% of this provider’s 794 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 14,667 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,911 662 S3 1 6
AMLODIPINE BESYLATE 1,158 711 2 1
SIMVASTATIN 1,077 625 3 2
LISINOPRIL 766 411 4 3
FUROSEMIDE 747 437 5 7
METFORMIN HCL 735 390 6 8
RANITIDINE HCL 654 281 7 27
LEVOTHYROXINE SODIUM 572 299 8 4
OMEPRAZOLE 508 303 9 5
POTASSIUM CHLORIDE 439 268 10 15
CARVEDILOL 433 287 11 20
MELOXICAM 423 177 12 30
GABAPENTIN 387 134 13 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 387 161 13 24
TRIAMTERENE-HCTZ 363 175 15 49
ZOLPIDEM TARTRATE 351 118 16 14
KLOR-CON M20 341 186 17 51
METOPROLOL TARTRATE 331 190 18 12
CLOPIDOGREL 281 191 19 32
GLIPIZIDE ER 266 173 20 86
CLONIDINE HCL 257 152 21 39
NEXIUM 252 119 22 23
ATORVASTATIN CALCIUM 247 169 23 11
TAMSULOSIN HCL 233 175 24 34
METOPROLOL SUCCINATE 229 124 25 19
HYDROCHLOROTHIAZIDE 218 111 26 10
GLIPIZIDE XL 212 150 27 134
FLUTICASONE PROPIONATE 211 56 28 28
CRESTOR 211 133 28 26
ENALAPRIL MALEATE 210 85 30 87
PLAVIX 209 134 31 46
ATENOLOL 208 105 32 18
SERTRALINE HCL 192 109 33 25
TRAMADOL HCL 192 99 33 17
LOSARTAN-HYDROCHLOROTHIAZIDE 191 92 35 41
FAMOTIDINE 187 66 36 45
LEVOFLOXACIN 184 83 37 79
AZITHROMYCIN 180 98 38 44
WARFARIN SODIUM 179 72 39 21
BISOPROLOL-HYDROCHLOROTHIAZIDE 178 104 40 93
DICLOFENAC SODIUM 176 79 41 95
PANTOPRAZOLE SODIUM 172 72 42 43
PRAVASTATIN SODIUM 171 112 43 9
DIGOXIN 168 89 44 62
COLCRYS 165 87 45 122
SPIRONOLACTONE 162 69 46 73
LOSARTAN POTASSIUM 161 134 47 16
DIOVAN 159 82 48 35
PROAIR HFA 156 78 49 69
HYDRALAZINE HCL 156 99 49 48
CYCLOBENZAPRINE HCL 154 32 R 51 66
PREDNISONE 146 75 52 42
OXYCODONE HCL 144 36 S2 53 124
IBUPROFEN 143 40 54 103
ISOSORBIDE MONONITRATE ER 143 106 54 60
AMLODIPINE BESYLATE-BENAZEPRIL 139 91 56 61
ALLOPURINOL 139 86 56 31
TRAZODONE HCL 130 59 58 47
LYRICA 129 41 59 91
VERAPAMIL ER 127 90 60 82
NIFEDIPINE ER 126 101 61 81
ADVAIR DISKUS 124 69 62 63
FENOFIBRATE 123 36 63 56
AMITRIPTYLINE HCL 122 53 R 64 70
NAPROXEN 121 65 65 100
ALENDRONATE SODIUM 117 94 66 36
COMBIVENT 114 72 67 110
LANTUS 112 56 68 50
SINGULAIR 110 34 69 83
AMOX TR-POTASSIUM CLAVULANATE 106 24 70 118
DOXAZOSIN MESYLATE 104 86 71 84
PROMETHAZINE HCL 104 51 R 71 77
NAMENDA 104 104 71 38
INSULIN SYRINGE 103 44 74 64
GLIMEPIRIDE 98 40 75 33
SPIRIVA 98 71 75 75
TRICOR 97 51 77 92
PHENYTOIN SODIUM EXTENDED 95 39 78 128
METHYLPREDNISOLONE 92 47 79 106
NIASPAN 88 25 80 127
KLOR-CON 10 87 39 81 96
JANUVIA 86 52 82 68
CIPROFLOXACIN HCL 85 46 83 58
METFORMIN HCL ER 82 71 84 54
DONEPEZIL HCL 82 82 84 29
GLIPIZIDE 80 35 86 53
VENTOLIN HFA 79 30 87 121
NOVOLOG 79 20 87 104
LOVASTATIN 77 28 89 40
DILTIAZEM 24HR ER 77 52 89 126
CARISOPRODOL 75 12 R 91 80
VESICARE 73 31 92 200
CITALOPRAM HBR 73 48 92 22
BENAZEPRIL HCL 68 60 94 57
CELEBREX 66 39 95 88
METOLAZONE 65 35 96 210
FLUOXETINE HCL 64 34 97 55
FINASTERIDE 63 62 98 110
GLYBURIDE 63 33 R 98 94
LEVEMIR 63 32 98 161
OXYBUTYNIN CHLORIDE ER 62 23 101 167
LACTULOSE 61 32 102 192
VENLAFAXINE HCL ER 60 18 103 89
DIOVAN HCT 60 50 103 59
GLYBURIDE-METFORMIN HCL 59 26 R 105 119
OXYCONTIN 58 0 S2 106 235
DILTIAZEM ER 57 34 107 147
PREMARIN 55 14 R 108 99
BENICAR 55 30 108 130
CEPHALEXIN 55 24 108 123
ATENOLOL-CHLORTHALIDONE 54 46 111 172
EXFORGE 53 44 112 211
RAMIPRIL 53 13 112 98
BACLOFEN 53 27 112 168
ESCITALOPRAM OXALATE 52 37 115 74
OXYCODONE-ACETAMINOPHEN 52 36 S2 115 109
NOVOLIN 70-30 51 25 117 144
LORAZEPAM 50 47 118 236
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.